Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination - PubMed (original) (raw)
Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination
J W Shiver et al. Ann N Y Acad Sci. 1995.
Abstract
Expression vectors encoding either HIV-1 gp160/rev, gp120, or rev alone were used for direct vaccination of mice and nonhuman primates. Each vaccine elicited long-lived (> 7 months) helper T cell responses in mice and monkeys as measured by in vitro proliferation of splenocytes following recombinant antigen treatment. Cytokine assays of the cell supernatants showed that approximately 100-fold more gamma-interferon than IL-4 was secreted during culture indicating that these vaccines elicited TH1-like responses. CD8+ CTL activities were also observed both in mice and rhesus. The gp120 and gp160/rev vaccines elicited antigen-specific antibodies, although these responses were more variable and lower magnitude for gp160/rev, and gp120 DNA-vaccinated African green monkeys had moderate levels of neutralizing antibodies. No antibodies were found against rev (an intracellular protein) with either rev vaccine. Similar antibody titers were obtained for gp120 by either intramuscular or intradermal injection although T cell responses were generally lower by intradermal route. These results indicate that DNA vaccines may provide a powerful means to elicit cellular and humoral immune responses against HIV.
Similar articles
- Anti-HIV env immunities elicited by nucleic acid vaccines.
Shiver JW, Davies ME, Yasutomi Y, Perry HC, Freed DC, Letvin NL, Liu MA. Shiver JW, et al. Vaccine. 1997 Jun;15(8):884-7. doi: 10.1016/s0264-410x(96)00251-4. Vaccine. 1997. PMID: 9234539 - Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
Laube LS, Burrascano M, Dejesus CE, Howard BD, Johnson MA, Lee WT, Lynn AE, Peters G, Ronlov GS, Townsend KS, et al. Laube LS, et al. Hum Gene Ther. 1994 Jul;5(7):853-62. doi: 10.1089/hum.1994.5.7-853. Hum Gene Ther. 1994. PMID: 7981310 - A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.
Buffa V, Negri DRM, Leone P, Bona R, Borghi M, Bacigalupo I, Carlei D, Sgadari C, Ensoli B, Cara A. Buffa V, et al. J Gen Virol. 2006 Jun;87(Pt 6):1625-1634. doi: 10.1099/vir.0.81706-0. J Gen Virol. 2006. PMID: 16690927 - Retroviral vectors for HIV immunotherapy.
Warner JF, Jolly D, Mento S, Galpin J, Haubrich R, Merritt J. Warner JF, et al. Ann N Y Acad Sci. 1995 Nov 27;772:105-16. doi: 10.1111/j.1749-6632.1995.tb44736.x. Ann N Y Acad Sci. 1995. PMID: 8546383 Review. No abstract available. - Polyvalent, recombinant HIV-1 virus-like particles: novel HIV-1 vaccine strategies.
Wagner R, Deml L, Wolf H. Wagner R, et al. Antibiot Chemother (1971). 1994;46:48-61. doi: 10.1159/000423633. Antibiot Chemother (1971). 1994. PMID: 7826039 Review. No abstract available.
Cited by
- DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN. Rosati M, et al. J Virol. 2005 Jul;79(13):8480-92. doi: 10.1128/JVI.79.13.8480-8492.2005. J Virol. 2005. PMID: 15956591 Free PMC article. - Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL. Barouch DH, et al. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7. doi: 10.1073/pnas.050417697. Proc Natl Acad Sci U S A. 2000. PMID: 10759543 Free PMC article. - Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL. Egan MA, et al. J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000. J Virol. 2000. PMID: 10906202 Free PMC article. - Harnessing DNA-induced immune responses for improving cancer vaccines.
Herrada AA, Rojas-Colonelli N, González-Figueroa P, Roco J, Oyarce C, Ligtenberg MA, Lladser A. Herrada AA, et al. Hum Vaccin Immunother. 2012 Nov 1;8(11):1682-93. doi: 10.4161/hv.22345. Epub 2012 Oct 30. Hum Vaccin Immunother. 2012. PMID: 23111166 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials